Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Cash from Financing Activities (2016 - 2026)

Perspective Therapeutics' Cash from Financing Activities history spans 16 years, with the latest figure at $164.4 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 1548.09% to $164.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $164.7 million, a 23.8% increase, with the full-year FY2025 number at $10.3 million, down 96.44% from a year prior.
  • Cash from Financing Activities hit $164.4 million in Q1 2026 for Perspective Therapeutics, up from -$13000.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CATX hit a ceiling of $166.3 million in Q1 2024 and a floor of -$80000.0 in Q1 2023.
  • Historically, Cash from Financing Activities has averaged $31.0 million across 5 years, with a median of $345000.0 in 2024.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 208010.0% in 2024 and later plummeted 103.77% in 2025.
  • Tracing CATX's Cash from Financing Activities over 5 years: stood at $28000.0 in 2022, then skyrocketed by 1157.14% to $352000.0 in 2023, then decreased by 1.99% to $345000.0 in 2024, then plummeted by 103.77% to -$13000.0 in 2025, then skyrocketed by 1264438.46% to $164.4 million in 2026.
  • Business Quant data shows Cash from Financing Activities for CATX at $164.4 million in Q1 2026, -$13000.0 in Q4 2025, and $213000.0 in Q3 2025.